Purchase Order HHSN264201800004M
Award Date 12/12/17
Potential Completion Date 1/31/18
Potential Value $23K
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Pleasanton, CA 94566, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
3
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a purchase order to 10X Genomics, Inc. for $23,534.00 on August 7, 2018. Performance is located in Pleasanton, California. The order period runs from August 7, 2018 through August 6, 2019. 10X Genomics supplies single-cell and spatial transcriptomics platforms, reagents, and consumables to federal research agencies.</p>
- The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a purchase order to 10X Genomics, Inc. for $24,084.00 on January 19, 2018. The order procures custom chromium single cell analysis reagents and consumables (3'/5' - 10X Genomics configuration). Performance occurs at 10X Genomics' facility in Pleasanton, California. The period of performance runs from January 19, 2018 through January 18, 2019, with ultimate completion targeted for February 28, 2018. The...
- <p>The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a purchase order to 10X Genomics, Inc. valued at $20,509.00 on July 9, 2018, with completion on July 8, 2019. Performance took place in Pleasanton, California. The order was issued on a firm fixed price basis with no small business set-aside. The source does not specify the items or services procured.</p>
- <p>The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a purchase order to 10X Genomics, Inc. for $21,600 on December 19, 2019. The order, which carries no set-aside designation, covers a platform supporting cell transcriptomics and cell-type identification and discovery. Work is performed at the vendor's facility in Pleasanton, California. The order is firm-fixed-price and concludes on December 26, 2019.</p>
- The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a purchase order to 10X Genomics, Inc. valued at $22,124.00 on September 20, 2019, with completion on September 27, 2019. The order is a firm fixed price, commercial item acquisition with no set-aside. Place of performance is Bethesda, Maryland. The purchase order procures genomic analysis instruments, consumables, or related bioinformatics products from 10X Genomics' single-cell and spatial transcriptomics...
- <p>The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a purchase order to 10X Genomics, Inc. valued at $22,887.00 on August 2, 2018, with completion by August 30, 2018. Work is performed in Pleasanton, California. The order is for commercial genomic analysis instruments, consumables, or reagents supplied on a firm fixed price basis. No set-aside applies.</p>
- <p>The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a purchase order to 10X Genomics, Inc. valued at $22,887.00 on July 5, 2018. Place of performance is Pleasanton, California. The order covers genomic analysis instruments, consumables, or bioinformatics software supplied by the vendor. No set-aside applied. Ultimate completion date is July 5, 2018.</p>
- The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a purchase order to 10X Genomics, Inc. valued at $23,045.50 on November 12, 2019, with completion by November 11, 2020. No set-aside was used. Performance occurs at Bethesda, Maryland. The order is priced on a firm fixed price basis. 10X Genomics supplies single-cell and spatial transcriptomics platforms, reagents, and consumables to federal research agencies; this order procures genomic analysis instruments or...
- The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a purchase order to 10X Genomics, Inc. for $19,100.00 on August 23, 2018. No set-aside was applied. Place of performance is Bethesda, Maryland. The order was completed by August 22, 2019. Pricing was firm fixed price for commercial genomic analysis instruments, consumables, or reagents—10X Genomics' core product portfolio in single-cell and spatial transcriptomics platforms supplied to federal research agencies.
- <p>The National Institute of Arthritis and Musculoskeletal and Skin Diseases issued a purchase order to 10X Genomics, Inc. valued at $21,581 with an award date of December 12, 2017. Work is performed in Bethesda, Maryland. The order covers genomic analysis instruments and consumables under a firm fixed price arrangement with a period of performance from December 12, 2017 through December 11, 2018.</p>